Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Annals of Thoracic Surgery|November 14, 1997
Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular diseaseR S Poston, M E Billingham, J Pollard, et al.
The Journal of Surgical Research|October 21, 1999
ICAM-1 affects reperfusion injury and graft function after cardiac transplantationR S Poston, D J Ing, M P Ennen, et al.
Circulation|November 18, 2000
Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery diseaseD N Miniati, E G Hoyt, B T Feeley, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 10, 1998
Ex vivo gene therapy prevents chronic graft vascular disease in cardiac allograftsR S Poston, M Ennen, J Pollard, et al.
Transplantation|October 9, 1999
Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection methodR S Poston, M J Mann, E G Hoyt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 1, 1993
Long survival with giant cell myocarditisH Ren, R S Poston, R H Hruban, et al.
Transplantation|June 14, 2000
Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipientsR S Poston, R C Robbins, B Chan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 1993
Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejectionK J Zehr, A Herskowitz, P C Lee, et al.
Circulation|November 1, 1994
Two decades of coronary artery bypass graft surgery in young adultsK J Zehr, P C Lee, R S Poston, et al.
Circulation|July 7, 1999
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft modelR S Poston, M Billingham, E G Hoyt, et al.
Pageof 2